181 related articles for article (PubMed ID: 38734648)
1. Ghana's path towards eliminating lymphatic filariasis.
Koray MH
Trop Med Health; 2024 May; 52(1):37. PubMed ID: 38734648
[TBL] [Abstract][Full Text] [Related]
2. Evaluating context-specific evidence-based quality improvement intervention on lymphatic filariasis mass drug administration in Northern Ghana using the RE-AIM framework.
Manyeh AK; Chirwa T; Ramaswamy R; Baiden F; Ibisomi L
Trop Med Health; 2021 Feb; 49(1):16. PubMed ID: 33602322
[TBL] [Abstract][Full Text] [Related]
3. Elimination of lymphatic filariasis as a public health problem in Malawi.
Chiphwanya J; Mkwanda S; Kabuluzi S; Mzilahowa T; Ngwira B; Matipula DE; Chaponda L; Ndhlova P; Katchika P; Mahebere Chirambo C; Moses P; Kumala J; Chiumia M; Barrett C; Betts H; Fahy J; Rebollo Polo M; Reimer L; Stanton MC; Thomas B; Freer S; Molyneux DH; Bockarie MJ; Mackenzie CD; Taylor MJ; Martindale S; Kelly-Hope LA
PLoS Negl Trop Dis; 2024 Feb; 18(2):e0011957. PubMed ID: 38363794
[TBL] [Abstract][Full Text] [Related]
4. The Elimination of Lymphatic Filariasis: A Strategy for Poverty Alleviation and Sustainable Development - Perspectives from the Philippines.
Galvez Tan JZ
Filaria J; 2003 Jul; 2(1):12. PubMed ID: 12914666
[TBL] [Abstract][Full Text] [Related]
5. Potential factors influencing lymphatic filariasis transmission in "hotspot" and "control" areas in Ghana: the importance of vectors.
Pi-Bansa S; Osei JHN; Frempong KK; Elhassan E; Akuoko OK; Agyemang D; Ahorlu C; Appawu MA; Koudou BG; Wilson MD; de Souza DK; Dadzie SK; Utzinger J; Boakye DA
Infect Dis Poverty; 2019 Feb; 8(1):9. PubMed ID: 30717788
[TBL] [Abstract][Full Text] [Related]
6. Using intervention mapping to design and implement quality improvement strategies towards elimination of lymphatic filariasis in Northern Ghana.
Manyeh AK; Ibisomi L; Baiden F; Chirwa T; Ramaswamy R
PLoS Negl Trop Dis; 2019 Mar; 13(3):e0007267. PubMed ID: 30908495
[TBL] [Abstract][Full Text] [Related]
7. Exploring factors affecting quality implementation of lymphatic filariasis mass drug administration in Bole and Central Gonja Districts in Northern Ghana.
Manyeh AK; Ibisomi L; Ramaswamy R; Baiden F; Chirwa T
PLoS Negl Trop Dis; 2020 Aug; 14(8):e0007009. PubMed ID: 32804967
[TBL] [Abstract][Full Text] [Related]
8. Lymphatic Filariasis (Elephantiasis) Elimination: A public health success and development opportunity.
Molyneux D
Filaria J; 2003 Sep; 2(1):13. PubMed ID: 13129436
[TBL] [Abstract][Full Text] [Related]
9. Lymphatic filariasis in Ghana: establishing the potential for an urban cycle of transmission.
Gbakima AA; Appawu MA; Dadzie S; Karikari C; Sackey SO; Baffoe-Wilmot A; Gyapong J; Scott AL
Trop Med Int Health; 2005 Apr; 10(4):387-92. PubMed ID: 15807803
[TBL] [Abstract][Full Text] [Related]
10. Stakeholders Perspectives on the Success Drivers in Ghana's National Health Insurance Scheme - Identifying Policy Translation Issues.
Fusheini A; Marnoch G; Gray AM
Int J Health Policy Manag; 2017 May; 6(5):273-283. PubMed ID: 28812815
[TBL] [Abstract][Full Text] [Related]
11. Contributions to the lymphatic filariasis elimination programme and post-elimination surveillance in China by NIPD-CTDR.
Sun DJ; Fang Y; Huang Y; Zhang Y
Adv Parasitol; 2020; 110():145-183. PubMed ID: 32563324
[TBL] [Abstract][Full Text] [Related]
12. Improving drug delivery strategies for lymphatic filariasis elimination in urban areas in Ghana.
Biritwum NK; Garshong B; Alomatu B; de Souza DK; Gyapong M; Kyelem D
PLoS Negl Trop Dis; 2017 May; 11(5):e0005619. PubMed ID: 28493966
[TBL] [Abstract][Full Text] [Related]
13. Rethinking district-level governance of malaria in Ghana: A narrative review.
Coleman NA
PLOS Glob Public Health; 2022; 2(7):e0000764. PubMed ID: 36962481
[TBL] [Abstract][Full Text] [Related]
14. Zambia: A Narrative Review of Success and Challenges in Lymphatic Filariasis Elimination.
Chimfwembe K; Shirley H; Baker N; Wamai R
Trop Med Infect Dis; 2024 Jan; 9(1):. PubMed ID: 38251218
[TBL] [Abstract][Full Text] [Related]
15. Lymphatic filariasis in Papua New Guinea: prospects for elimination.
Bockarie MJ; Kazura JW
Med Microbiol Immunol; 2003 Feb; 192(1):9-14. PubMed ID: 12592558
[TBL] [Abstract][Full Text] [Related]
16. Evolution of the monitoring and evaluation strategies to support the World Health Organization's Global Programme to Eliminate Lymphatic Filariasis.
Lammie PJ; Gass KM; King J; Deming MS; Addiss DG; Biswas G; Ottesen EA; Henderson R
Int Health; 2020 Dec; 13(Suppl 1):S65-S70. PubMed ID: 33349883
[TBL] [Abstract][Full Text] [Related]
17. Elimination of lymphatic filariasis: do we have the drugs to complete the job?
Bockarie MJ; Deb RM
Curr Opin Infect Dis; 2010 Dec; 23(6):617-20. PubMed ID: 20847694
[TBL] [Abstract][Full Text] [Related]
18. Elimination of Lymphatic Filariasis in Shandong Province, China, 1957-2015.
Huang X; Deng X; Kou J; Liu X; Wang H; Cheng P; Gong M
Vector Borne Zoonotic Dis; 2020 Dec; 20(12):875-881. PubMed ID: 32795160
[TBL] [Abstract][Full Text] [Related]
19. How elimination of lymphatic filariasis as a public health problem in the Kingdom of Cambodia was achieved.
Khieu V; Or V; Tep C; Odermatt P; Tsuyuoka R; Char MC; Brady MA; Sidwell J; Yajima A; Huy R; Ramaiah KD; Muth S
Infect Dis Poverty; 2018 Feb; 7(1):15. PubMed ID: 29463307
[TBL] [Abstract][Full Text] [Related]
20. Community views on mass drug administration for filariasis: a qualitative evidence synthesis.
Taylor M; Thomas R; Oliver S; Garner P
Cochrane Database Syst Rev; 2022 Feb; 2(2):CD013638. PubMed ID: 35174482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
